You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,307,368


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,307,368
Title:Compositions containing alpha-2-adrenergic agonist components
Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
Inventor(s): Graham; Richard (Irvine, CA), Bakhit; Peter (Huntington Beach, CA), Olejnik; Orest (Coto De Caza, CA)
Assignee: ALLERGAN, INC. (Irvine, CA)
Application Number:15/481,169
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 10,307,368

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 10,307,368, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape in the United States.

What is a Patent?

A patent is a government grant that gives the inventor exclusive rights to make, use, and sell their invention for a specified period, usually 20 years from the filing date of the patent application[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO plays a critical role in the patent process, from receiving and examining patent applications to issuing patents[2].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical aspect of patent quality and is often debated in terms of whether patents are overly broad or too narrow[3].

Metrics for Measuring Patent Scope

Researchers use various metrics to measure patent scope, including independent claim length and independent claim count. These metrics have been validated by showing their explanatory power for several correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Claims in a Patent

Claims are the most important part of a patent application, as they define the scope of the invention. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[3].

Analyzing US Patent 10,307,368

Patent Details

US Patent 10,307,368 is a utility patent that was granted on June 4, 2019. To analyze this patent, one would typically start by reviewing the patent document available through the USPTO's Patent Public Search tool or other patent search resources[4].

Claim Structure

The claims section of the patent will outline what the inventor considers to be the novel and non-obvious aspects of the invention. For example, if US Patent 10,307,368 pertains to a technological innovation, the claims might include detailed descriptions of the system, method, or apparatus, along with any specific limitations or variations.

Independent and Dependent Claims

  • Independent Claims: These claims will define the broadest scope of the invention. For instance, if the patent is for a new type of software, an independent claim might describe the overall system architecture.
  • Dependent Claims: These claims will further narrow down the invention by adding specific details or limitations. For example, a dependent claim might specify a particular algorithm used within the software system.

Claim Language and Scope

The language used in the claims is crucial. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims. This is because narrower claims are often clearer and less likely to be rejected due to prior art or other issues[3].

Patent Allowance Rates and Continuation Procedures

Understanding Allowance Rates

The probability of receiving a patent can be measured through various allowance rates, including the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates provide insights into the likelihood of a patent being granted based on different stages of the examination process[1].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuation-in-part (CIP) applications, can significantly impact the patent allowance rate. These procedures allow applicants to revise and resubmit their applications, potentially increasing the chances of patent grant[1].

Searching and Analyzing Patents

Tools and Resources

The USPTO provides several tools and resources for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources help in identifying prior art, understanding the patent family, and accessing detailed information about patent applications and grants[4].

Public Search Facility and PTRCs

The Public Search Facility in Alexandria, VA, and local PTRCs offer access to patent and trademark information, along with trained staff to assist in search techniques. These resources are invaluable for conducting thorough patent searches[4].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could streamline the process for resolving patent disputes involving smaller entities. This initiative aims to address the high costs and complexities associated with patent litigation[5].

International Harmonization

The global patent system is moving towards greater integration, with initiatives like the Common Citation Document (CCD) and Global Dossier aimed at harmonizing patent search and examination processes across different IP offices[4].

Key Takeaways

  • Patent Scope and Claims: Understanding the scope and claims of a patent is essential for determining the breadth of protection granted.
  • Metrics for Patent Scope: Independent claim length and count are useful metrics for measuring patent scope.
  • Continuation Procedures: These procedures can significantly impact the likelihood of patent grant.
  • Search Tools and Resources: The USPTO provides various tools for searching and analyzing patents.
  • Legal and Policy Considerations: Initiatives like small claims patent courts and international harmonization are shaping the patent landscape.

FAQs

What is the role of the USPTO in the patent process?

The USPTO is responsible for receiving, examining, and granting U.S. patents and registering trademarks.

How are patent scope and claims measured?

Patent scope can be measured using metrics such as independent claim length and independent claim count.

What are continuation procedures in patent applications?

Continuation procedures, like RCEs and CIPs, allow applicants to revise and resubmit their applications to increase the chances of patent grant.

Where can I find detailed information about a specific patent?

You can use the USPTO's Patent Public Search tool or visit the Public Search Facility and PTRCs for detailed information about patents.

Is there a proposed small claims patent court?

Yes, there have been studies and discussions on the feasibility of a small claims patent court to address the high costs and complexities of patent litigation.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. U.S. Patent and Trademark Office. (n.d.). U.S. Patent and Trademark Office (USPTO). USA.gov.
  3. SSRN. (2016, September 29). Patent Claims and Patent Scope. Social Science Research Network.
  4. USPTO. (2018, October 18). Search for patents. USPTO.
  5. ACUS. (n.d.). U.S. Patent Small Claims Court. Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,307,368

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,307,368

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 033539 ⤷  Subscribe
Australia 2001273269 ⤷  Subscribe
Australia 2005220199 ⤷  Subscribe
Australia 2005280259 ⤷  Subscribe
Australia 2011250793 ⤷  Subscribe
Australia 7326901 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.